Glagov phenomenon

Jump to navigation Jump to search

WikiDoc Resources for Glagov phenomenon

Articles

Most recent articles on Glagov phenomenon

Most cited articles on Glagov phenomenon

Review articles on Glagov phenomenon

Articles on Glagov phenomenon in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Glagov phenomenon

Images of Glagov phenomenon

Photos of Glagov phenomenon

Podcasts & MP3s on Glagov phenomenon

Videos on Glagov phenomenon

Evidence Based Medicine

Cochrane Collaboration on Glagov phenomenon

Bandolier on Glagov phenomenon

TRIP on Glagov phenomenon

Clinical Trials

Ongoing Trials on Glagov phenomenon at Clinical Trials.gov

Trial results on Glagov phenomenon

Clinical Trials on Glagov phenomenon at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Glagov phenomenon

NICE Guidance on Glagov phenomenon

NHS PRODIGY Guidance

FDA on Glagov phenomenon

CDC on Glagov phenomenon

Books

Books on Glagov phenomenon

News

Glagov phenomenon in the news

Be alerted to news on Glagov phenomenon

News trends on Glagov phenomenon

Commentary

Blogs on Glagov phenomenon

Definitions

Definitions of Glagov phenomenon

Patient Resources / Community

Patient resources on Glagov phenomenon

Discussion groups on Glagov phenomenon

Patient Handouts on Glagov phenomenon

Directions to Hospitals Treating Glagov phenomenon

Risk calculators and risk factors for Glagov phenomenon

Healthcare Provider Resources

Symptoms of Glagov phenomenon

Causes & Risk Factors for Glagov phenomenon

Diagnostic studies for Glagov phenomenon

Treatment of Glagov phenomenon

Continuing Medical Education (CME)

CME Programs on Glagov phenomenon

International

Glagov phenomenon en Espanol

Glagov phenomenon en Francais

Business

Glagov phenomenon in the Marketplace

Patents on Glagov phenomenon

Experimental / Informatics

List of terms related to Glagov phenomenon

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vanessa Cherniauskas, M.D. [2]

Synonyms and keywords: Glagov's phenomenon; Glagov's remodeling

Overview

Glagov phenomenon denotes the adaptive enlargement of coronary artery in response to plaque formation. Lumen area is preserved during the early stage of coronary artery disease and lumen encroachment becomes evident until the lesion occupies greater than 40% of the internal elastic lamina area.[1] Thus, angiography-detectable stenosis and significant functional impairment may be delayed despite the presence of a fairly sizable atherosclerotic plaque.

Historical Perspective

Based on the study of human left main coronary arteries obtained at autopsy by Seymour Glagov et al. in 1987,[1] it was concluded that during the initial development of atherosclerosis, coronary artery enlarges in parallel with the growth of plaque and a nearly normal cross-sectional lumen area is maintained, as the internal elastic lamina area directly correlates with the plaque area. Lumen area starts to diminish in close relation to the percentage of stenosis, defined as the ratio of plaque area to internal elastic lamina area, for values above 40 percent.

Clinical Significance

Atherosclerosis is a disease of the vessel wall. Since coronary angiography only allows visualization of the arterial lumen, atherosclerotic burden and disease extent may be underestimated due to the compensatory coronary enlargement in response to plaque formation which preserves the ordinary lumen size. Arterial narrowing becomes appreciable on coronary angiography until the plaque occupies greater than 40% of the internal elastic lamina area. Therefore, a normal-sized coronary artery on angiogram does not rule out the presence of atherosclerotic plaque nor certainly indicates a small plaque burden.

References

  1. 1.0 1.1 Glagov, S.; Weisenberg, E.; Zarins, CK.; Stankunavicius, R.; Kolettis, GJ. (1987). "Compensatory enlargement of human atherosclerotic coronary arteries". N Engl J Med. 316 (22): 1371–5. doi:10.1056/NEJM198705283162204. PMID 3574413. Unknown parameter |month= ignored (help)